Goodwin

Partner

David R. Chen is a life sciences and technology transactions lawyer based on the West Coast and in Asia. He is an expert on strategic and cross-border licensing, collaboration, and strategic partner transactions, technology-/data-driven transactions, and commercial transactions in the life sciences and technology sectors.

David represents life sciences companies of all sizes and stages, from emerging biotechs/med-techs to large multi-national pharmaceutical/medical tech companies. He spent 14+ years living and practicing in Asia, where he assisted foreign and local companies in transactions involving China, Japan, S. Korea, S.E. Asia, and worldwide territories. David’s life sciences expertise encompasses the entire life sciences value chain, from early-stage collaboration on drug discovery, in-licensing and out-licensing of pre-clinical and clinical-stage drug candidates, CMO, CRO, and CSO arrangements, supply and distribution arrangements, promotion and commercialization arrangements, pipeline optimization and divestiture transactions, and cross-industry digital health initiatives.

David also regularly advises technology, software, e-commerce, mobile app, mobile gaming, digital media, and data-driven companies on their strategic transactions, partnering arrangements, and investments, and regularly advises companies across a broad range of industries on China and Hong Kong privacy and data protection laws and compliance.

David is a California native, and is fluent in English and Mandarin Chinese.

JD 2008 Boston University; MA International Relations 2009 Boston University; LLM Chinese Law 2008 Tsinghua University; BA Business Economics and Sociology 2002 University of California, Los Angeles